Onconova Therapeutics Inc. (NASDAQ:ONTX) dropped 3.8% during mid-day trading on Thursday . The stock traded as low as $3.31 and last traded at $3.32, with a volume of 62,944 shares trading hands. The stock had previously closed at $3.45.

The firm’s market cap is $9.11 million. The stock’s 50 day moving average is $4.85 and its 200 day moving average is $4.98.

Onconova Therapeutics (NASDAQ:ONTX) last announced its quarterly earnings results on Thursday, May 12th. The biopharmaceutical company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.08. On average, analysts predict that Onconova Therapeutics Inc. will post ($7.40) EPS for the current year.

Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.